Status:
COMPLETED
Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia
Lead Sponsor:
Taylor's University
Conditions:
Hyperphosphatemia
End Stage Renal Disease on Dialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This multi-centred randomized, open label-controlled trial consists of hemodialysis (HD) patients identified with hyperphosphatemia (\>1.78mmol/L). The intervention group received a phosphate mobile a...
Detailed Description
This study is a multi-centred randomized, open label-controlled trial where a total of 66 HD patients (33 intervention vs 33 control) with hyperphosphatemia were recruited from government, private and...
Eligibility Criteria
Inclusion
- Patients aged 18 years old and above.
- Patients were undergoing maintenance HD treatment for more than three months.
- Patients were on hemodialysis treatment for 4 hours per session, three times a week.
- Kt/V value (a numerical formula value to determine hemodialysis treatment adequacy. K is dialyser clearance of urea, t is dialysis time, and V is the volume of distribution of urea, approximately equal to the patient's total body water) is 1.2 and above each session.
- Patients were able to read English or Malay or Mandarin.
- Patients were on the single type of phosphate binder.
- Patients were having serum phosphorus above 1.78mmol/l and above for more than three months.
- Patients were not seen by a dietitian for the past one year for phosphate education.
- Patients did not have ward admission for the past three months.
- Patients did not have dementia or developmental delay.
- Patients owned and able to use a smartphone.
- Patients were able to use at least one comprehensive mobile application independently.
- Patients had access to the internet/data plan.
- Patients were willing to adhere to all study requirements and protocol.
- Patients were willing to accept the publication of data without exposing their name.
Exclusion
- Patients were on incremental or acute hemodialysis.
- Patients had ward admission three months prior to the study and during the study period.
- Patients were terminally ill.
- Patients had cognitive impairment or physical disabilities (visual, hand dexterity, etc.) hindering interview and PMA utilisation.
- Patients had visual impairment or blind hindering the interview or the use of PMA.
- Patients were unable to self-care and dependent.
- Patients stayed in an institutionalised setting.
- Patients had undergone parathyroidectomy.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2020
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04789876
Start Date
November 1 2019
End Date
February 29 2020
Last Update
March 10 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusat Rawatan Dialisis Islah
Batu Caves, Selangor, Malaysia, 68100
2
National Kidney Foundation Malaysia
Petaling Jaya, Selangor, Malaysia, 46100
3
Hospital Kuala Lumpur
Kuala Lumpur, Malaysia, 50586